Skip to main content
OpenTrials
Completed

NCT Number: NCT06395974

Fetal Renal Artery Doppler in Patients With Preeclampsia

Preeclampsia is a major devastating disorder affects 2:10% of pregnancies worldwide. preeclampsia may be associated with placental insufficiency which may cause fetal blood redistribution to essential organs like brain, heart, kidney.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Female

Study type

Observational

Primary location

Assiut university hospital

Asyut, Egypt

About this study

Preeclampsia is a major devastating medical condition that affects pregnant women after 20 weeks of pregnancy. It affects 2:10% of pregnancies worldwide according to World Health Organisation with higher incidence in developing countries.

Vascular endothelial dysfunction due to abnormal placentation is believed to be the main cause of multi-organ failure and uteroplacental insufficiency that occur in preeclampsia leading to major adverse effects in both mother and fetus.

Placental insufficiency causes a redistribution of fetal blood to essential organs ; brain, heart and adrenal glands by decreasing their vascular resistance on expense of peripheral organs. Changes occur in fetal renal circulation in preeclampsia is still area of debate with conflicting results in literature. Doppler ultrasound examination of vasculature of selected organs such as kidneys may have a role in detection of hemodynamic rearrangements that occur in cases of placental insufficiency and preeclampsia.

Also, Three dimensional power Doppler plays a role in comprehensive analysis of placental perfusion. It has a promising results regarding prediction of preeclampsia during early pregnancy and may have insights into prediction of adverse neonatal outcomes in late trimester.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • a) Preeclampsia:
  • Women with preeclampsia >28 weeks of pregnancy.
  • Singleton pregnancy.
  • Women with intrauterine growth restriction and abnormal amniotic fluid volume to simulate real world data.

b) Control:

  • Women with healthy pregnancy matched by closest gestational age.

Exclusion criteria

  • ● Multiple pregnancy.
  • Known Congenital fetal malformations.
  • Women with other comorbidity such as ischemic heart disease, DM, Autoimmune disorders, kidney disease, neurological disorders, liver or haematological disorders.
  • Women unable to provide informed consent.
  • Women who refuse to participate

Treatment and study plan

fetal ultrasound

Other

2D, 3D , Doppler ultrasound

Primary outcomes

  1. fetal renal artery doppler indices

    Time frame: 1 year

    the difference between the Fetal renal artery Doppler indices between preeclamptic patients and women with healthy pregnancy

  2. Middle cerberal artery doppler indices , Umbilical artery doppler indices and placental volume

    Time frame: 1 year

Secondary outcomes

  1. neonatal outcome

    Time frame: 1 year

    the ability of Fetal renal artery Doppler in prediction of neonatal complications.

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Fetal Renal Artery Doppler and Three Dimensional Power Doppler Study of Placenta in Patients With Preeclampsia and Its Role in Prediction of Adverse Neonatal Outcomes

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
May 2, 2024
Registry last updated
May 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.